Elucidating the specific pharmacological mechanism of action (MOA) of In a natural way happening compounds is often hard. While Tarselli et al. (60) produced the first de novo synthetic pathway to conolidine and showcased that this naturally occurring compound effectively suppresses responses to the two chemically induced and inflammation-derived a